Immune cells from lymph nodes for advanced HER2-negative breast cancer
Treatments studied
Part of Cancer, Skin clinical trials.
This trial tests a treatment using your own immune cells taken from lymph nodes near the tumor. The cells are grown in a lab and given back to you to fight cancer, along with another drug chosen by your doctor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 70.
- You have advanced or metastatic HER2-negative breast cancer that cannot be cured with standard treatments.
- You have not had this type of cell therapy before.
- You have tumors that can be measured on scans and lymph nodes that can be surgically removed.
- You are healthy enough for surgery and the treatment, with good organ function (like blood counts, liver, kidneys, and heart).
- You must stop certain cancer treatments for a few weeks before joining.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment for advanced HER2-negative breast cancer. Doctors will take immune cells from lymph nodes near your tumor, grow them in a lab, and then give them back to you along with chemotherapy and immunotherapy. This approach aims to help your body fight the cancer more effectively.
This trial tests whether using a patient's own immune cells from lymph nodes near the tumor, given as a treatment before surgery, can help shrink HER2-negative breast cancer. It is for people whose cancer has not responded fully to two cycles of initial chemotherapy.
This trial tests whether taking immune cells from your lymph nodes and giving them back to you can help shrink breast cancer that has not responded fully to initial chemotherapy. It is for women with HER2-negative breast cancer who have had stable disease after two cycles of a standard chemotherapy combination.
This trial tests a personalized vaccine made from your own immune cells (dendritic cells) that are trained to attack cancer cells. It is for women with HER2-negative advanced breast cancer that has spread or cannot be removed by surgery. The vaccine is designed to target a specific marker (FAM53B) found on tumor cells.
This trial tests a new type of immune cell therapy (CAR-NK cells) that targets specific proteins on breast cancer cells. It's for people with advanced HER2-positive or triple-negative breast cancer who have tried other treatments or can't take them.
This trial tests a new treatment using T cells taken from your lymph nodes to fight advanced solid tumors that have not responded to standard therapies. The goal is to see if this approach can help shrink tumors or slow their growth.
Hear when a new Breast Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.